EXPLAINED: What is the new Swiss coronavirus drug and how does it work?
FOR MEMBERS

EXPLAINED: What is the new Swiss coronavirus drug and how does it work?

While the focus in Switzerland, and elsewhere, has been primarily on vaccines in the past few months, a new medication may also offer hope in the fight against Covid-19. This is what we know about this drug.

Swiss-American antibody drug ‘effective at preventing Covid infection’

Swiss-American antibody drug ‘effective at preventing Covid infection’

Switzerland’s Roche reports promising results from anti-Covid cocktail

Switzerland’s Roche reports promising results from anti-Covid cocktail

Roche seals takeover of cancer data upstart Flatiron

Roche seals takeover of cancer data upstart Flatiron

Swiss pharma buys US firm fighting rare tumours

Swiss pharma buys US firm fighting rare tumours

US approves new cancer test developed by Swiss group Roche

US approves new cancer test developed by Swiss group Roche

Swiss are European patent champions once again

Swiss are European patent champions once again

Swiss company’s Zika test to be used in US

Swiss company’s Zika test to be used in US

Basel approves tallest building in Switzerland

Basel approves tallest building in Switzerland

Roche profits fall due to strong Swiss franc

Roche profits fall due to strong Swiss franc

Biogen announces billion-franc drugs plant

Biogen announces billion-franc drugs plant

Roche sales rise in Q1 despite strong franc

Roche sales rise in Q1 despite strong franc

Roche takes over US cancer analysis firm

Roche takes over US cancer analysis firm

placeholder image

Restructuring costs reduce Roche profits

Roche to buy ‘molecule’ to boost antiobiotics

Roche to buy ‘molecule’ to boost antiobiotics

Roche invests in US cancer specialist firm

Roche invests in US cancer specialist firm

US approves Roche test for HIV and hepatitus

US approves Roche test for HIV and hepatitus

Roche seeks fast track for Ebola virus test

Roche seeks fast track for Ebola virus test

Roche reveals towering plans for Basel site

Roche reveals towering plans for Basel site

Roche touts new breast cancer drug success

Roche touts new breast cancer drug success

Strong franc eats into Roche first-half profits

Strong franc eats into Roche first-half profits

Roche swallows US breast cancer drug firm

Roche swallows US breast cancer drug firm

Italy seeking damages from Swiss drug giants

Italy seeking damages from Swiss drug giants

Investigators search Roche offices in China

Investigators search Roche offices in China

Roche acquires US diagnostics testing firm

Roche acquires US diagnostics testing firm

Cancer drugs boost Roche profits for 2013

Cancer drugs boost Roche profits for 2013

Roche drug linked to fatal skin reactions in Canada

Roche drug linked to fatal skin reactions in Canada

Roche joins Basel firm to fight hospital ‘superbug’

Roche joins Basel firm to fight hospital ‘superbug’

Roche announces global plan to create 500 jobs

Roche announces global plan to create 500 jobs

Roche head talks up Novartis ‘relationship’

Roche head talks up Novartis ‘relationship’

Lufthansa chief to take over as Roche chairman

Lufthansa chief to take over as Roche chairman

India denies revoking Roche cancer drug patent

India denies revoking Roche cancer drug patent

Credit Suisse and Roche post jump in profits

Credit Suisse and Roche post jump in profits

Severe flu season boosts Roche drug sales

Severe flu season boosts Roche drug sales

Roche boosts dividend on higher profits

Roche boosts dividend on higher profits

Roche profits tumble in first six months of 2012

Roche profits tumble in first six months of 2012

placeholder image

Roche blames strong Swiss franc for profit dip

placeholder image

Drug giant Roche posts strong profit rise

placeholder image

Roche halts drug supply to Greek hospitals over unpaid bills

Roche in takeover bid for US firm Illumina

Roche in takeover bid for US firm Illumina

placeholder image

Roche issues counterfeit drug warning in US

Roche extends hostile takeover bid for Illumina

Roche extends hostile takeover bid for Illumina

Roche extends hostile $5.7 billion Illumina bid

Roche extends hostile $5.7 billion Illumina bid

Roche raises hostile bid for US Illumina

Roche raises hostile bid for US Illumina

Roche could withdraw hostile Illumina bid

Roche could withdraw hostile Illumina bid

Roche urges Illumina shareholders to revolt

Roche urges Illumina shareholders to revolt